CLASS ACTION UPDATE for FATE, SHC and ARBK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / February 9, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

FATE Shareholders Click Here: https://www.zlk.com/pslra-1/fate-therapeutics-class-action-submission-form?prid=36423&wire=1
SHC Shareholders Click Here: https://www.zlk.com/pslra-1/sotera-health-class-action-lawsuit-submission-form?prid=36423&wire=1
ARBK Shareholders Click Here: https://www.zlk.com/pslra-1/argo-blockchain-lawsuit-submission-form?prid=36423&wire=1

* ADDITIONAL INFORMATION BELOW *

Fate Therapeutics, Inc. FATE

FATE Lawsuit on behalf of: investors who purchased April 2, 2020 - January 5, 2023
Lead Plaintiff Deadline : March 22, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/fate-therapeutics-class-action-submission-form?prid=36423&wire=1

According to the filed complaint, during the class period, Fate Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the global collaboration and option agreement for cell-based cancer immunotherapies that the Company entered into with Janssen Biotech, Inc. (the "Janssen Collaboration Agreement") was less sustainable than Fate had represented to investors; (ii) accordingly, certain the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources; (iii) as a result, Fate had overstated the impact of the Janssen Collaboration Agreement's on Fate's long-term clinical and commercial profitability; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Sotera Health Company SHC

This lawsuit is on behalf of all persons or entities that purchased or otherwise acquired Sotera common stock: (i) pursuant and/or traceable to the Company's initial public offering conducted on or around November 20, 2020; (ii) pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021; and/or (iii) between November 20, 2020 and September 19, 2022, inclusive.
Lead Plaintiff Deadline : March 27, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sotera-health-class-action-lawsuit-submission-form?prid=36423&wire=1

According to the filed complaint, 1) long before the Company's initial public offering, Sotera's executives and controlling shareholders knew of the significant health risks associated with exposure to elevated levels of Ethylene Oxide ("EtO"); 2) despite that knowledge, Sotera failed to employ adequate and effective emissions control systems at its sterilization facilities and often subverted whatever control systems the Company did have; 3) these failures and subversions allowed dangerous amounts of toxic EtO fumes to pollute the air surrounding those facilities and exposed people living in the adjacent communities to significantly increased cancer risks; 4) even after Sotera's closure of its Illinois EtO processing plant, the Company continued to operate multiple sterilization facilities that emitted dangerous levels of EtO; and 5) to the extent that the Company purported to warn of liability risks from the EtO cancer-related lawsuits, Sotera failed to disclose the true extent of those risks by withholding information from investors regarding the inadequacy or subversion of its EtO emissions control systems.

Argo Blockchain plc ARBK

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Argo American Depository Shares pursuant and/or traceable to the documents issued in connection with the Company's initial public offering conducted on or about September 23, 2021; and/or (b) Argo securities between September 23, 2021 and October 10, 2022, both dates inclusive.
Lead Plaintiff Deadline : March 27, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/argo-blockchain-lawsuit-submission-form?prid=36423&wire=1

According to the filed complaint, (i) Argo was highly susceptible to and/or suffered from significant capital constraints, electricity and other costs, and network difficulties; (ii) the foregoing issues hampered Argo's ability to mine Bitcoin or Bitcoin equivalents, execute its business strategy, meet its obligations, and operate its Helios facility; (iii) as a result, Argo's business was less sustainable than defendants had led investors to believe; (iv) accordingly, Argo's business and financial prospects were overstated; and (v) as a result, the documents issued in connection with the Company's initial public offering and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP